Shalabh Gupta, M.D.

Shalabh Gupta, M.D.

Chief Executive OfficeratUnicycive Therapeutics· In proxies 2022–2025

Pay in FY2025-2% from the year before · Unicycive Therapeutics stock -27.3% the same year

Shalabh Gupta, M.D. was paid $2.4M in FY2025 (Dec), down 2%. Unicycive Therapeutics stock fell 27.3% that year.

Pay$100 in the stock at the end of FY21 → $17
Pay is from the Summary Compensation Table of each Unicycive Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Unicycive TherapeuticsPublic company · 4 yr
    • Chief Executive Officer2022 – Present · 4 yrStock in role -82%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?